Education
About Us
Working with TipRanks
Follow Us
Senseonics Holdings Inc (SENS)
:SENS
SENS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.40
Previous CloseN/A
Volume3.00M
Average Volume (3M)6.48M
Market Cap
$371.82M
Enterprise Value$302.00M
Total Cash (Recent Filing)$74.91M
Total Debt (Recent Filing)$61.05M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Nov 11, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding814,680,900
10 Day Avg. Volume5,002,303
30 Day Avg. Volume6,477,824
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue11.14
Enterprise Value/Gross Profit56.39
Enterprise Value/Ebitda-5.10
Forecast
1Y Price Target
$1.22Price Target Upside183.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company's updated financial model reflects higher expectations for revenue growth, with significant increases in projected revenues for 2026 and 2027.
Product DevelopmentThe approval and launch of Eversense 365 in the EU is expected soon, offering significant unmet need for long-term glucose monitoring.
Strategic PartnershipsAbbott recently took a 5% stake in Senseonics, which came with a right of first negotiation and quarterly updates on Senseonics’ R&D programs.
Bears Say
Net LossSenseonics reported a net loss of $0.02 per share, in-line with consensus estimates.
Operational ChallengesManagement believes that the company could reach operational break even by the end of 2027 if the growth trajectory remains on track.
Senseonics Holdings News
SENS FAQ
What was Senseonics Holdings Inc’s price range in the past 12 months?
Senseonics Holdings Inc lowest stock price was $0.25 and its highest was $1.40 in the past 12 months.
What is Senseonics Holdings Inc’s market cap?
Senseonics Holdings Inc’s market cap is $371.82M.
When is Senseonics Holdings Inc’s upcoming earnings report date?
Senseonics Holdings Inc’s upcoming earnings report date is Nov 11, 2025 which is in 81 days.
How were Senseonics Holdings Inc’s earnings last quarter?
Senseonics Holdings Inc released its earnings results on Aug 06, 2025. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Senseonics Holdings Inc overvalued?
According to Wall Street analysts Senseonics Holdings Inc’s price is currently Undervalued.
Does Senseonics Holdings Inc pay dividends?
Senseonics Holdings Inc does not currently pay dividends.
What is Senseonics Holdings Inc’s EPS estimate?
Senseonics Holdings Inc’s EPS estimate is -0.02.
How many shares outstanding does Senseonics Holdings Inc have?
Senseonics Holdings Inc has 814,680,900 shares outstanding.
What happened to Senseonics Holdings Inc’s price movement after its last earnings report?
Senseonics Holdings Inc reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went down -6.122%.
Which hedge fund is a major shareholder of Senseonics Holdings Inc?
Currently, no hedge funds are holding shares in SENS
Senseonics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.22 (183.72% Upside)
$1.22 (183.72% Upside)
Blogger Sentiment
Bullish
SENS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 184.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.33%
12-Months-Change
Fundamentals
Return on Equity
-102.61%
Trailing 12-Months
Asset Growth
34.70%
Trailing 12-Months
Company Description
Senseonics Holdings Inc
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
SENS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in new patient starts and revenue, driven by effective marketing and strategic partnerships. However, challenges remain in terms of financial losses and dependency on payer adjustments. Overall, the positive aspects of growth and strategic positioning seem to outweigh the ongoing financial challenges.View all SENS earnings summariesSENS Stock 12 Month Forecast
Average Price Target
$1.22
▲(183.72% Upside)
Technical Analysis
Ownership Overview
4.39% Insiders
3.88% Mutual Funds
7.96% Other Institutional Investors
78.54% Public Companies and
Individual Investors